Mainz Biomed B.V. (MYNZ)
NASDAQ: MYNZ · IEX Real-Time Price · USD
0.349
-0.031 (-8.16%)
At close: Jul 19, 2024, 4:00 PM
0.359
+0.010 (2.75%)
Pre-market: Jul 22, 2024, 7:33 AM EDT

Mainz Biomed B.V. Revenue

In the year 2023, Mainz Biomed B.V. had annual revenue of $895.48K with 69.00% growth. Revenue in the quarter ending December 31, 2023 was $214.76K with 11.11% year-over-year growth.

Revenue (ttm)
$895.48K
Revenue Growth
+69.00%
P/S Ratio
8.53
Revenue / Employee
$12,612
Employees
71
Market Cap
7.64M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023895.48K365.60K69.00%
Dec 31, 2022529.88K-47.47K-8.22%
Dec 31, 2021577.35K83.78K16.98%
Dec 31, 2020493.57K212.17K75.40%
Dec 31, 2019281.39K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
XWELL 31.77M
Precipio 15.81M
Vivos Therapeutics 13.36M
iCoreConnect 9.03M
NeuroMetrix 5.27M
Kineta 5.16M
Innovative Eyewear 1.39M
Revenue Rankings